Cargando…
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update
In 2010, eight Austrian medical societies proposed a joint position statement on the management of metabolic lipid disorders for the prevention of vascular complications. An updated and extended version of these recommendations according to the current literature is presented, referring to the prima...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839054/ https://www.ncbi.nlm.nih.gov/pubmed/27052248 http://dx.doi.org/10.1007/s00508-016-0993-x |
_version_ | 1782428081252728832 |
---|---|
author | Toplak, Hermann Ludvik, Bernhard Lechleitner, Monika Dieplinger, Hans Föger, Bernhard Paulweber, Bernhard Weber, Thomas Watschinger, Bruno Horn, Sabine Wascher, Thomas C. Drexel, Heinz Brodmann, Marianne Pilger, Ernst Rosenkranz, Alexander Pohanka, Erich Oberbauer, Rainer Traindl, Otto Roithinger, Franz Xaver Metzler, Bernhard Haring, Hans-Peter Kiechl, Stefan |
author_facet | Toplak, Hermann Ludvik, Bernhard Lechleitner, Monika Dieplinger, Hans Föger, Bernhard Paulweber, Bernhard Weber, Thomas Watschinger, Bruno Horn, Sabine Wascher, Thomas C. Drexel, Heinz Brodmann, Marianne Pilger, Ernst Rosenkranz, Alexander Pohanka, Erich Oberbauer, Rainer Traindl, Otto Roithinger, Franz Xaver Metzler, Bernhard Haring, Hans-Peter Kiechl, Stefan |
author_sort | Toplak, Hermann |
collection | PubMed |
description | In 2010, eight Austrian medical societies proposed a joint position statement on the management of metabolic lipid disorders for the prevention of vascular complications. An updated and extended version of these recommendations according to the current literature is presented, referring to the primary and secondary prevention of vascular complications in adults, taking into consideration the guidelines of other societies. The “Austrian Lipid Consensus – 2016 update” provides guidance for individualized risk stratification and respective therapeutic targets, and discusses the evidence for reducing vascular endpoints with available lipid-lowering therapies. Furthermore, specific management in key patient groups is outlined, including subjects presenting with coronary, cerebrovascular, and/or peripheral atherosclerosis; diabetes mellitus and/or metabolic syndrome; nephropathy; and familial hypercholesterolemia. |
format | Online Article Text |
id | pubmed-4839054 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-48390542016-05-11 Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update Toplak, Hermann Ludvik, Bernhard Lechleitner, Monika Dieplinger, Hans Föger, Bernhard Paulweber, Bernhard Weber, Thomas Watschinger, Bruno Horn, Sabine Wascher, Thomas C. Drexel, Heinz Brodmann, Marianne Pilger, Ernst Rosenkranz, Alexander Pohanka, Erich Oberbauer, Rainer Traindl, Otto Roithinger, Franz Xaver Metzler, Bernhard Haring, Hans-Peter Kiechl, Stefan Wien Klin Wochenschr Austrian Lipid Consensus In 2010, eight Austrian medical societies proposed a joint position statement on the management of metabolic lipid disorders for the prevention of vascular complications. An updated and extended version of these recommendations according to the current literature is presented, referring to the primary and secondary prevention of vascular complications in adults, taking into consideration the guidelines of other societies. The “Austrian Lipid Consensus – 2016 update” provides guidance for individualized risk stratification and respective therapeutic targets, and discusses the evidence for reducing vascular endpoints with available lipid-lowering therapies. Furthermore, specific management in key patient groups is outlined, including subjects presenting with coronary, cerebrovascular, and/or peripheral atherosclerosis; diabetes mellitus and/or metabolic syndrome; nephropathy; and familial hypercholesterolemia. Springer Vienna 2016-04-06 2016 /pmc/articles/PMC4839054/ /pubmed/27052248 http://dx.doi.org/10.1007/s00508-016-0993-x Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Austrian Lipid Consensus Toplak, Hermann Ludvik, Bernhard Lechleitner, Monika Dieplinger, Hans Föger, Bernhard Paulweber, Bernhard Weber, Thomas Watschinger, Bruno Horn, Sabine Wascher, Thomas C. Drexel, Heinz Brodmann, Marianne Pilger, Ernst Rosenkranz, Alexander Pohanka, Erich Oberbauer, Rainer Traindl, Otto Roithinger, Franz Xaver Metzler, Bernhard Haring, Hans-Peter Kiechl, Stefan Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update |
title | Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update |
title_full | Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update |
title_fullStr | Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update |
title_full_unstemmed | Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update |
title_short | Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update |
title_sort | austrian lipid consensus on the management of metabolic lipid disorders to prevent vascular complications: a joint position statement issued by eight medical societies. 2016 update |
topic | Austrian Lipid Consensus |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839054/ https://www.ncbi.nlm.nih.gov/pubmed/27052248 http://dx.doi.org/10.1007/s00508-016-0993-x |
work_keys_str_mv | AT toplakhermann austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT ludvikbernhard austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT lechleitnermonika austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT dieplingerhans austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT fogerbernhard austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT paulweberbernhard austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT weberthomas austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT watschingerbruno austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT hornsabine austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT wascherthomasc austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT drexelheinz austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT brodmannmarianne austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT pilgerernst austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT rosenkranzalexander austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT pohankaerich austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT oberbauerrainer austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT traindlotto austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT roithingerfranzxaver austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT metzlerbernhard austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT haringhanspeter austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update AT kiechlstefan austrianlipidconsensusonthemanagementofmetaboliclipiddisorderstopreventvascularcomplicationsajointpositionstatementissuedbyeightmedicalsocieties2016update |